Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2023 | Insights into the UCL CAR T program

Claire Roddie • 3 Jun 2023
ASCO 2023
Acute Lymphoblastic Leukemia General Leukemia Lymphoma Multiple Myeloma CAR-T

Claire Roddie, MD, PhD, University College London Cancer Institute, London, UK, shares insights into the University College London (UCL) CAR T program. Dr Roddie discusses the diverse range of CAR T studies being conducted within the program both in hematological malignancies and solid tumors. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Claire Roddie

Updates in ALL
Bijal Shah et al. • 14 Apr 2023
3:38
Mechanisms of resistance to CAR-T in ALL: T-cell fitness, antigen loss and immunological rejection
Claire Roddie • 3 Jun 2023
4:45
Safety and efficacy of obe-cel in R/R adult B-ALL: results of the pivotal FELIX study
Claire Roddie • 3 Jun 2023
5:01
Early safety and efficacy data of AUTO1 in R/R indolent B-cell lymphoma
Claire Roddie • 10 Jun 2021

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
The content of VJHemOnc is intended for healthcare professionals